All About the New Obesity Drugs Causing a Big Stir: QuickTake

Sept. 29, 2023, 7:44 PM UTC

Obesity is among the world’s most common health conditions, but for years medicine has had few effective approaches to offer short of surgery. That’s why there’s been so much excitement about a new class of drugs that’s helping patients shed dozens of pounds at far lower risk. One of the treatments — Novo Nordisk’s Wegovy — has been shown to reduce heart attacks and strokes.
Drugmakers are racing to scale up production of the few medications approved so far and test new versions. Yet there are big hurdles that could keep the medications from many or most of the billion ...

Learn more about Bloomberg Law or Log In to keep reading:

See Breaking News in Context

Bloomberg Law provides trusted coverage of current events enhanced with legal analysis.

Already a subscriber?

Log in to keep reading or access research tools and resources.